Charles River Laboratories International (CRL) FY2023 results: revenue $4.1 billion, up 3.9% on the year
Charles River Laboratories International, Inc. (CRL) reported revenue of $4.1 billion for fiscal 2023, the year ended 30 December 2023, up 3.9% on the year before. Net income was $475 million, down 2.4%, and diluted earnings per share $9.22. The figures are the company's own, from the 10-K it filed with the SEC on 14 February 2024.
Revenue
$4.1 billion
+3.9% on the year
FY2016FY2023
Operating margin
14.9%
16.4% a year earlier
FY2016FY2023
Net income
$475 million
-2.4% on the year
FY2016FY2023
Diluted EPS
$9.22
-2.7% on the year
FY2016FY2023
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2023
FY2022
FY2021
On the year
Last 8 years
Operating cash flow
684
620
761
+10.4%
Capital expenditure
319
325
229
-1.9%
Free cash flow
365
295
532
+23.9%
Free cash flow margin
8.8%
7.4%
15.0%
Cash from investing
-563
-608
-1,438
Cash from financing
-85.5
-42.4
673
Depreciation and amortisation
314
304
266
+3.4%
Share-based compensation
72.0
73.6
71.5
-2.1%
Buybacks
24.2
38.7
40.7
-37.5%
Diluted shares, weighted
51m
51m
51m
+0.3%
Shares outstanding at period end
51m
51m
50m
+0.8%
Balance sheet
$ million
FY2023
FY2022
FY2021
On the year
Last 8 years
Shareholders' equity
3,597
2,976
2,535
+20.9%
Non-controlling interest
5.4
4.8
4.2
+12.7%
Redeemable equity
56.7
42.4
53.0
+33.7%
Debt
2,647
2,708
2,664
-2.2%
Operating lease liabilities
419
390
253
+7.6%
Finance lease liabilities
26.2
28.3
24.5
-7.6%
Other liabilities
1,443
1,454
1,491
-0.7%
Total liabilities and equity
8,195
7,603
7,024
+7.8%
Fixed assets
1,640
1,466
1,291
+11.9%
Goodwill
3,095
2,850
2,712
+8.6%
Intangible assets
864
955
1,061
-9.5%
Investments
n/a
n/a
1.1
Cash and equivalents
277
234
241
+18.3%
Receivables
780
752
643
+3.7%
Inventory
380
256
199
+48.6%
Other assets
1,159
1,090
876
+6.3%
Total assets
8,195
7,603
7,024
+7.8%
10-K for the year ended 30 December 2023, filed 14 February 2024: the filing.